Warning:
This document is being maintained for historical purposes, but is now out of date. To view current guidelines please visit:
- STD Treatment Guidelines at http://www.cdc.gov/STD/treatment
1993 Sexually Transmitted Diseases Treatment Guidelines
09/24/1993 SUGGESTED CITATION Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR 1993;42(No. RR-14): {inclusive page numbers}. CIO Responsible for this publication: National Center for Prevention Services, Division of Sexually Transmitted Diseases and HIV Prevention Late Syphilis Late (tertiary) syphilis refers to patients with gumma and patients with cardiovascular syphilis, but not to neurosyphilis. Nonallergic patients without evidence of neurosyphilis should be treated with the following regimen. Recommended Regimen - Benzathine penicillin G, 7.2 million units total, administered as 3 doses of 2.4 million units IM, at 1-week intervals. Other Management Considerations Patients with symptomatic late syphilis should undergo CSF examination before therapy. Some experts treat all patients who have cardiovascular syphilis with a neurosyphilis regimen. The complete management of patients with cardiovascular or gummatous syphilis is beyond the scope of these guidelines. These patients should be managed in consultation with experts. Follow-Up There is minimal evidence regarding follow-up of patients infected with late syphilis. Clinical response depends partly on the nature of the lesions. Management of Sex Partners Refer to General Principles, Management of Sex Partners. Special Considerations Penicillin Allergy - Patients allergic to penicillin should be treated according to treatment regimens recommended for late latent syphilis. Pregnancy - Pregnant patients who are allergic to penicillin should be treated with penicillin, after desensitization, if necessary (see Management of the Patient With a History of Penicillin Allergy and Syphilis During Pregnancy). HIV Infection - Refer to Syphilis Among HIV-Infected Patients.
This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.